ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08945
-0,01%
Bitcoin
66.920,04
-0,24%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Bioenvision (MM) (BIVN)

  7. Bioenvision (MM) (BIVN) News

BIVN

Bioenvision (BIVN)

Bioenvision (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BIVN
DatumZeitQuelleÜberschriftSymbolFirma
11/04/201714h30GlobeNewswire Inc.MonoSol Rx Appoints James S. Scibetta to Board of DirectorsNASDAQ:BIVNBioenvision (MM)
23/10/200723h40PR Newswire (US)HealthShares(TM) Announces Change to the HealthShares(TM) Emerging Cancer IndexNASDAQ:BIVNBioenvision (MM)
22/10/200722h50PR Newswire (US)Bioenvision Shareholders Approve Acquisition by Genzyme CorporationNASDAQ:BIVNBioenvision (MM)
10/10/200720h57PR Newswire (US)Delaware Court Approves Bioenvision, Genzyme Joint PetitionNASDAQ:BIVNBioenvision (MM)
05/10/200723h00Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
05/10/200723h00Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
05/10/200714h34Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
05/10/200714h34Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
04/10/200723h14Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
04/10/200723h14Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
01/10/200715h17Edgar (US Regulatory)Bioenvision Inc (Other) (SC 13D/A)NASDAQ:BIVNBioenvision (MM)
27/09/200714h45PR Newswire (US)Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding ShareNASDAQ:BIVNBioenvision (MM)
27/09/200714h31Edgar (US Regulatory)Bioenvision Inc (Other) (DFAN14A)NASDAQ:BIVNBioenvision (MM)
27/09/200714h30Edgar (US Regulatory)Bioenvision Inc (Other) (SC 13D/A)NASDAQ:BIVNBioenvision (MM)
20/09/200720h15Edgar (US Regulatory)Bioenvision Inc (Other) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
19/09/200723h11Edgar (US Regulatory)Bioenvision Inc (Other)NASDAQ:BIVNBioenvision (MM)
06/09/200715h49PR Newswire (US)Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues CompanyNASDAQ:BIVNBioenvision (MM)
16/08/200714h00Business WireBioenvision Provides Evoltra(R) (clofarabine) Regulatory UpdateNASDAQ:BIVNBioenvision (MM)
28/07/200700h24PR Newswire (US)Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
26/07/200722h30Business WireBioenvision, Inc. Says Securities Class Action Litigation Without MeritNASDAQ:BIVNBioenvision (MM)
16/07/200715h00Business WireDr. Andrew N. Schiff and Steven A. Elms Resign from Bioenvision Board of DirectorsNASDAQ:BIVNBioenvision (MM)
10/07/200720h44PR Newswire (US)/C O R R E C T I O N -- Genzyme Corporation/NASDAQ:BIVN
10/07/200715h27PR Newswire (US)Genzyme Completes Tender Offer to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
02/07/200716h45PR Newswire (US)Genzyme Extends Tender Offer to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
27/06/200719h30PR Newswire (US)Genzyme Corporation Moves Closer to Acquiring Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
29/05/200716h09PR Newswire (US)Genzyme Corporation to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
08/05/200713h00Business WireBioenvision Reports Third Quarter 2007 Financial ResultsNASDAQ:BIVNBioenvision (MM)
07/05/200713h02Business WireBioenvision Receives $7.4 Million in Warrant Exercises by Perseus-Soros Biopharmaceutical Fund & SCO CapitalNASDAQ:BIVNBioenvision (MM)
03/05/200713h02Business WireBioenvision to Present at 2007 UBS Global Generic and Specialty Pharmaceuticals ConferenceNASDAQ:BIVNBioenvision (MM)
01/05/200713h02Business WireBioenvision to Hold Fiscal 2007 Third Quarter Financial Results Conference Call on Tuesday, May 8, 2007NASDAQ:BIVNBioenvision (MM)
 Showing the most relevant articles for your search:NASDAQ:BIVN

Kürzlich von Ihnen besucht

BIT
P1XEW9
NLBNPIT1XEW9 20240920 22.5
NASDAQ
LUFK
Lufkin
BIT
P1X5M8
NLBNPIT1X5M8 20240920 19
BIT
P1XYD7
NLBNPIT1XYD7 20241218 35...
NASDAQ
SHOO
Steven Madden
LSE
0UC3
Norwegian Cruise Line
NYSE
ADE
BOV
T1DG34
Transdigm
BIT
P1UDL0
NLBNPIT1UDL0 20351219 16...
USOTC
WACC
Westamerica (CE)
DGFX
XSRUSDT
xensor
LSE
CHS
BIT
P1YYX3
NLBNPIT1YYX3 20351221 85...
NYSE
GFG
BIT
P1ZL40
NLBNPIT1ZL40 20991231 23...
BIT
P1ZG47
NLBNPIT1ZG47 20241220 3.5
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten